The challenge of type 1 diabetes mellitus (Q35823958)

10 August 2017

1 reference

title

The challenge of type 1 diabetes mellitus (English)

1 reference

10 August 2017

0 references

Larissa Eiselein

1

1 reference

10 August 2017

Henry J Schwartz

series ordinal

2

1 reference

10 August 2017

John C Rutledge

series ordinal

3

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

231-236

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

CD3-specific antibody-induced active tolerance: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Cost-of-illness studies in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Bioethical theory and practice in genetic screening for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Pathophysiological mechanisms of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Glycolaldehyde-Modified Low Density Lipoprotein Leads Macrophages to Foam Cells via the Macrophage Scavenger Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

The pathophysiology of diabetic complications: how much does the glucose hypothesis explain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

HL-A antigens and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

The role of advanced glycation end products in the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Effect of the Aldose Reductase Inhibitor Tolrestat on Nerve Conduction Velocity, NA/K ATPase Activity, and Polyols in Red Blood Cells, Sciatic Nerve, Kidney Cortex, and Kidney Medulla of Diabetic Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Advanced glycation end-products and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ILAR.45.3.231

21 January 2018

Identifiers

DOI

10.1093/ILAR.45.3.231

1 reference

10 August 2017

1 reference